Delivery Order SPE2DB22D3019-SPE2DB25FK4FX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,351.88 to AmerisourceBergen Drug Corp for the supply of Valacyclovir HCL 1 gram tablets (90-count units) on September 5, 2025, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents performance at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count) with a ceiling value of $1,421.78. The award was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, under a firm fixed-price contract structure with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,701.77 to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count) with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order, awarded on September 4, 2025, represents a non-competitive set-aside award under the company's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,848.18 to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,066.16 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Valacyclovir HCL 1 Gram Tablets (90-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a pediatric or routine pharmaceutical procurement under the DLA's Medical Supply Chain operations. The award was made on a competitive basis with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order valued at $2,350.40 to AmerisourceBergen Drug Corp for the supply of Valacyclovir HCL 1 Gram tablets (90-count) under a firm fixed price contract. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-competitive delivery order represents a routine pharmaceutical supply transaction supporting...
- The Defense Logistics Agency awarded a $3,422.09 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Valacyclovir HCL 1 gram tablets (90-count units). This is a non-set-aside competitive award with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,589.52 for Valacyclovir HCl 1 gram tablets (90-count packaging) on June 12, 2025, with completion scheduled for June 13, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order valued at $1,081.17 to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count supply) on June 18, 2025, with completion scheduled for June 20, 2025. This firm fixed-price delivery order, placed without set-aside provisions, represents a competitive award to the prime contractor, which maintains its corporate headquarters in Conshohocken, Pennsylvania—the designated place of performance. The award is executed under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valacyclovir HCL 1 gram tablets (90-count units) with a contract value of $3,608.64. This delivery order, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4FXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valacyclovir HCL 1 gram tablets (90-count units) under a firm fixed-price contract valued at $8,724.37. The order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location in Conshohocken, PA 19428. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies to support military healthcare programs worldwide. The valacyclovir order exemplifies the antiviral pharmaceutical products delivered through this strategic contract vehicle, which supports Defense Health Agency operations and other government healthcare systems with brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 9/16/25 |